JAK2 and neoplasm: Some studies reported that activation of STAT1 could promote the apoptosis of tumor cells [75], while another studies reported that high levels of ROS promote JAK2 phosphorylation, leading to the pJAK2-STAT1 signaling mediated anti-apoptosis of tumor cells [76], this may explain why high levels of inflammation promote drug resistance in tumor cells.